Nonprofit

Emily's Entourage

Philadelphia, PA
|
www.emilysentourage.org

  • About Us

    Emily’s Entourage is an innovative 501(c)3 foundation that accelerates research and drug development for the final 10% of people with cystic fibrosis (CF), including those with nonsense mutations. By providing critical leadership and coordination, Emily’s Entourage drives high-impact research, cultivates multi-stakeholder collaboration, and facilitates information exchange to speed breakthroughs. Since 2011, Emily's Entourage has awarded millions of dollars in research grants, launched a CF gene therapy company recently acquired by a large pharmaceutical company, and led worldwide efforts to drive high-impact research and drug development. The organization has been featured in national media, including the New York Times, STAT, CNN, People, and more.

    Emily’s Entourage is an innovative 501(c)3 foundation that accelerates research and drug development for the final 10% of people with cystic fibrosis (CF), including those with nonsense mutations. By providing critical leadership and coordination, Emily’s Entourage drives high-impact research, cultivates multi-stakeholder collaboration, and facilitates information exchange to speed breakthroughs. Since 2011, Emily's Entourage has awarded millions of dollars in research grants, launched a CF gene therapy company recently acquired by a large pharmaceutical company, and led worldwide efforts to drive high-impact research and drug development. The organization has been featured in national media, including the New York Times, STAT, CNN, People, and more.

    Issue Areas Include

    Location

    • Philadelphia, PA, USA

    Current listings by Emily's Entourage

    JobsLocationDate Posted
    Development and Events CoordinatorPhiladelphia, PANovember 21, 2024
    Illustration

    Discover Your Calling

    Find opportunities to change the world with the latest social-impact job, internship, and volunteer listings. Plus, explore resources for taking action in your community.